Superior in vitro anticancer effect of biomimetic paclitaxel and triptolide co-delivery system in gastric cancer

As a well-known anticancer drug, paclitaxel (PTX), a first-line chemotherapeutic agent, remains unsatisfactory for gastric cancer therapy. It is reported that triptolide (TPL) could enhance the anti-gastric cancer effect of PTX. Considering the poor solubility of both drugs, we developed a red blood...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Siwan, Jiang, Hui, Wang, Jia, Wu, Haisi, Wu, Ting, Ni, Mengnan, Zhao, Qianqian, Ji, You, Zhang, Ziting, Tang, Chunming, Xu, Huae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Department of Journal of Biomedical Research 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383169/
https://www.ncbi.nlm.nih.gov/pubmed/34421008
http://dx.doi.org/10.7555/JBR.35.20210102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383169/
https://www.ncbi.nlm.nih.gov/pubmed/34421008
http://dx.doi.org/10.7555/JBR.35.20210102

Ejemplares similares